Edwards bumps up sales forecast on TAVR strength in Q3

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 05 Nov, 16:02 UTC

Going forward, the heart valve maker expects procedure volumes to rise following positive study data and expanded Medicare reimbursement.

science

Sources

• T2Edwards bumps up sales forecast on TAVR strength in Q3BioPharma Dive / Healthcare Dive / MedTech Dive05 Nov, 16:02